Anti-CMV therapy, what next? A systematic review
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in immunocompromised patients and after congenital infection. There are currently drugs available to treat HCMV infection, targeting viral polymerase, whose use is complicated by toxicity and the emergence of resistance....
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2023-11-01
|
| Collection: | Frontiers in Microbiology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1321116/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|